Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Telomir Pharmaceuticals Inc (TELO)

Telomir Pharmaceuticals Inc (TELO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Telomir Pharmaceuticals Inc 100 SE 2ND STREET SUITE 2000 -1009 MIAMI FL 33131 USA

www.telomirpharma.com Employees: 9 P: 813-864-2558

Description:

Telomir Pharmaceuticals Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Telomir Pharmaceuticals Inc. is based in BALTIMORE.

Key Statistics

Overview:

Market Capitalization, $K 153,972
Enterprise Value, $K 154,072
Shares Outstanding, K 29,610
Annual Sales, $ 0 K
Annual Net Income, $ -13,070 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,990 K
EBIT, $ -10,480 K
EBITDA, $ -8,870 K
% of Institutional Shareholders 0.00%
Float, K 29,610
% Float 100.00%
Short Volume Ratio 0.74

Growth:

1-Year Return 4.00%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -0.48
EPS Growth vs. Prev Qtr -300.00%
EPS Growth vs. Prev Year 456.27%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TELO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,087.91%
Return-on-Assets % -806.34%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 340.98
Book Value/Share 0.01
Interest Coverage -6.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar